Bootmaker Dr Martens warns trading in season ahead crucial after 9% half-year revenue drop
Nov 12 (Reuters) - British bootmaker Dr Martens DOCS.L reported a drop in first-half revenue on Thursday and warned that trading in the key season ahead would be crucial to its full-year result, leaving a wide range of possible outcomes for both sales and profit.
"The weakness in boots combined with the impact of the planned critical changes to our DTC proposition means that the H1 performance we’re announcing today is disappointing," CEO Ije Nwokorie said in a statement, adding that demand for shoes and sandals was not enough to offset to decline in demand for boots.
Revenue dropped 9.2%, in constant currency terms, to £290.4 million ($384.98 million) in the six months to September 27, with weaker performance in the second quarter than the first and a bigger-than-expected drop in the UK.
($1 = 0.7543 pounds)